Seven weeks after post-injection, linc00630 overexpression group dramatically increased tumor metastasis, which was determined by the metastasis loci numbers in Hemotoxylin and Eosin staining (H&E) staining, relative to the control group (Figure 3E and 3F). Here, LINC00630 is linked to neoplasm.